Multiple-dose efficacy comparison topical carbonic anhydrase inhibitors multiple-dose twice-daily efficacy topical carbonic anhydrase inhibitor racemic compound active S-enantiomer four-center double-masked placebo-controlled parallel study sezolamide hydrochloride placebo patients bilateral primary open angle glaucoma ocular hypertension morning intraocular pressure mm Hg eyes washout ocular hypotensive medications Parallel diurnal curves study day curves days compounds significant lowering intraocular pressure AM hours dose hours AM dose sezolamide activity mean percent change intraocular pressure prestudy sezolamide peak effect hours dose administration sezolamide hours dose administration decrease intraocular pressure differences significant 